FRONT CARDIOVASC MED 润色咨询

Frontiers in Cardiovascular Medicine

出版年份:暂无数据 年文章数:3784 投稿命中率: 开通期刊会员,数据随心看

出版周期:C 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1267, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=830, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么,是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:心血管;冠心病<br>经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享:分享下自己综述的投稿旅程:<br>12 Jun 2021:submitted manuscript.<br>02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021:Interactive review forum activated.<br>16 Sep 2021:Submitting Author re-submitted manuscript.<br>20 Sep 2021:Review of Review Editor 1 finalized.<br>21 Sep 2021:Review of Review Editor 2 finalized.<br>27 Sep 2021:Article accepted for publication.<br>总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:心血管内科<br>经验分享:11周了,还没分配编辑,撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231130/0a4251b44f9f4b298875276d57e794f3/b5a28ac3b71d4667ac577be2fe8dc8b2.jpg, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2024-01-21 ms2000000620153331 来自陕西省

    23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1267, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=830, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么,是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:心血管;冠心病<br>经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享:分享下自己综述的投稿旅程:<br>12 Jun 2021:submitted manuscript.<br>02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021:Interactive review forum activated.<br>16 Sep 2021:Submitting Author re-submitted manuscript.<br>20 Sep 2021:Review of Review Editor 1 finalized.<br>21 Sep 2021:Review of Review Editor 2 finalized.<br>27 Sep 2021:Article accepted for publication.<br>总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:心血管内科<br>经验分享:11周了,还没分配编辑,撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231130/0a4251b44f9f4b298875276d57e794f3/b5a28ac3b71d4667ac577be2fe8dc8b2.jpg, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2022-06-16 ms3720148795955021

    今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!

    14

    展开14条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1267, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=830, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么,是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:心血管;冠心病<br>经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享:分享下自己综述的投稿旅程:<br>12 Jun 2021:submitted manuscript.<br>02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021:Interactive review forum activated.<br>16 Sep 2021:Submitting Author re-submitted manuscript.<br>20 Sep 2021:Review of Review Editor 1 finalized.<br>21 Sep 2021:Review of Review Editor 2 finalized.<br>27 Sep 2021:Article accepted for publication.<br>总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:心血管内科<br>经验分享:11周了,还没分配编辑,撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231130/0a4251b44f9f4b298875276d57e794f3/b5a28ac3b71d4667ac577be2fe8dc8b2.jpg, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2022-07-22 1259390fm84暂无昵称

    见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1267, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=830, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么,是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:心血管;冠心病<br>经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享:分享下自己综述的投稿旅程:<br>12 Jun 2021:submitted manuscript.<br>02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021:Interactive review forum activated.<br>16 Sep 2021:Submitting Author re-submitted manuscript.<br>20 Sep 2021:Review of Review Editor 1 finalized.<br>21 Sep 2021:Review of Review Editor 2 finalized.<br>27 Sep 2021:Article accepted for publication.<br>总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:心血管内科<br>经验分享:11周了,还没分配编辑,撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231130/0a4251b44f9f4b298875276d57e794f3/b5a28ac3b71d4667ac577be2fe8dc8b2.jpg, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2023-08-22 ms6000001243617632 来自湖北省

    大家都推荐审稿人了么,是不是没推就会慢很多

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1267, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=830, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么,是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:心血管;冠心病<br>经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享:分享下自己综述的投稿旅程:<br>12 Jun 2021:submitted manuscript.<br>02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021:Interactive review forum activated.<br>16 Sep 2021:Submitting Author re-submitted manuscript.<br>20 Sep 2021:Review of Review Editor 1 finalized.<br>21 Sep 2021:Review of Review Editor 2 finalized.<br>27 Sep 2021:Article accepted for publication.<br>总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:心血管内科<br>经验分享:11周了,还没分配编辑,撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231130/0a4251b44f9f4b298875276d57e794f3/b5a28ac3b71d4667ac577be2fe8dc8b2.jpg, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2023-09-04 ms2000000203298966 来自浙江省

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向:心血管;冠心病
    经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1267, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=830, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么,是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:心血管;冠心病<br>经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享:分享下自己综述的投稿旅程:<br>12 Jun 2021:submitted manuscript.<br>02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021:Interactive review forum activated.<br>16 Sep 2021:Submitting Author re-submitted manuscript.<br>20 Sep 2021:Review of Review Editor 1 finalized.<br>21 Sep 2021:Review of Review Editor 2 finalized.<br>27 Sep 2021:Article accepted for publication.<br>总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:心血管内科<br>经验分享:11周了,还没分配编辑,撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231130/0a4251b44f9f4b298875276d57e794f3/b5a28ac3b71d4667ac577be2fe8dc8b2.jpg, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2021-09-28 隐形的翅膀

    审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0
    经验分享:分享下自己综述的投稿旅程:
    12 Jun 2021:submitted manuscript.
    02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor.
    02 Sep 2021:Interactive review forum activated.
    16 Sep 2021:Submitting Author re-submitted manuscript.
    20 Sep 2021:Review of Review Editor 1 finalized.
    21 Sep 2021:Review of Review Editor 2 finalized.
    27 Sep 2021:Article accepted for publication.
    总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错

    14

    展开14条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1267, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=830, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么,是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:心血管;冠心病<br>经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享:分享下自己综述的投稿旅程:<br>12 Jun 2021:submitted manuscript.<br>02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021:Interactive review forum activated.<br>16 Sep 2021:Submitting Author re-submitted manuscript.<br>20 Sep 2021:Review of Review Editor 1 finalized.<br>21 Sep 2021:Review of Review Editor 2 finalized.<br>27 Sep 2021:Article accepted for publication.<br>总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:心血管内科<br>经验分享:11周了,还没分配编辑,撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231130/0a4251b44f9f4b298875276d57e794f3/b5a28ac3b71d4667ac577be2fe8dc8b2.jpg, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2022-05-19 ms4000000327895144

    之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。

    9

    展开9条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1267, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=830, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么,是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:心血管;冠心病<br>经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享:分享下自己综述的投稿旅程:<br>12 Jun 2021:submitted manuscript.<br>02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021:Interactive review forum activated.<br>16 Sep 2021:Submitting Author re-submitted manuscript.<br>20 Sep 2021:Review of Review Editor 1 finalized.<br>21 Sep 2021:Review of Review Editor 2 finalized.<br>27 Sep 2021:Article accepted for publication.<br>总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:心血管内科<br>经验分享:11周了,还没分配编辑,撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231130/0a4251b44f9f4b298875276d57e794f3/b5a28ac3b71d4667ac577be2fe8dc8b2.jpg, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2023-05-16 ms9000001815965090 来自陕西省

    请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1267, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=830, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么,是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:心血管;冠心病<br>经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享:分享下自己综述的投稿旅程:<br>12 Jun 2021:submitted manuscript.<br>02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021:Interactive review forum activated.<br>16 Sep 2021:Submitting Author re-submitted manuscript.<br>20 Sep 2021:Review of Review Editor 1 finalized.<br>21 Sep 2021:Review of Review Editor 2 finalized.<br>27 Sep 2021:Article accepted for publication.<br>总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:心血管内科<br>经验分享:11周了,还没分配编辑,撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231130/0a4251b44f9f4b298875276d57e794f3/b5a28ac3b71d4667ac577be2fe8dc8b2.jpg, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2023-04-20 ms8000001488135201 来自陕西省

    审稿速度:24.0 | 投稿命中率:5.0
    偏重的研究方向:心血管内科
    经验分享:11周了,还没分配编辑,撤了撤了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2183059, encodeId=55d421830598e, content=23年7月投的,24年1月接收。等的时间有点长,着急毕业不推荐。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=176c8575575, createdName=ms2000000620153331, createdTime=Sun Jan 21 21:36:51 CST 2024, time=2024-01-21, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1226773, encodeId=6df91226e733f, content=今年会不会上预警呢?疯狂扩刊中,国人发表占比近一半!!看了好多帖子,有预测今年可能会被预警,刚中一篇,惊吓!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1267, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Thu Jun 16 11:52:24 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234081, encodeId=e7a2123408112, content=见了鬼了这个杂志 审稿人同意接受了 但是编辑部竟然给拒绝了 这究竟是什么套路, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=830, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd472576188, createdName=1259390fm84暂无昵称, createdTime=Fri Jul 22 21:44:41 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154102, encodeId=a07a2154102aa, content=大家都推荐审稿人了么,是不是没推就会慢很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21c65468152, createdName=ms6000001243617632, createdTime=Tue Aug 22 21:49:41 CST 2023, time=2023-08-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156078, encodeId=448f21560e8d2, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:心血管;冠心病<br>经验分享:07.09submitted 07.28interactive review forum activated(major revision) 08.07review of reviewer1 finalized 08.10review of reviewer2 finalized, accepted 09.04published, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70808239379, createdName=ms2000000203298966, createdTime=Mon Sep 04 20:22:01 CST 2023, time=2023-09-04, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1055535, encodeId=85f81055535e6, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2490.0<br>经验分享:分享下自己综述的投稿旅程:<br>12 Jun 2021:submitted manuscript.<br>02 Jul 2021:Editorial Office Frontiers in Cardiovascular Medicine assigned new Associate Editor. <br>02 Sep 2021:Interactive review forum activated.<br>16 Sep 2021:Submitting Author re-submitted manuscript.<br>20 Sep 2021:Review of Review Editor 1 finalized.<br>21 Sep 2021:Review of Review Editor 2 finalized.<br>27 Sep 2021:Article accepted for publication.<br>总共历时4个半月,收到录用消息实在太开心啦,2021年JCR分区:Q1,IF,6.05,杂志效率还算不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Tue Sep 28 00:36:24 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220843, encodeId=b03212208433f, content=之前一个大修,两个reject,一个endorsed,修回后现在两个finalized,两个reject,还有希望接收吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=337, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2d265535018, createdName=ms4000000327895144, createdTime=Thu May 19 09:12:51 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2134922, encodeId=735d213492241, content=请问下大家,审稿人在 Is a statistician required to evaluate this study? 这个问题中写的Yes,是会有什么其他审查流程吗?需要提交原始数据吗?<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bfd88686839, createdName=ms9000001815965090, createdTime=Tue May 16 10:57:03 CST 2023, time=2023-05-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2127304, encodeId=f997212e30404, content=审稿速度:24.0 | 投稿命中率:5.0<br>偏重的研究方向:心血管内科<br>经验分享:11周了,还没分配编辑,撤了撤了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231130/0a4251b44f9f4b298875276d57e794f3/b5a28ac3b71d4667ac577be2fe8dc8b2.jpg, createdBy=37236544321, createdName=ms8000001488135201, createdTime=Thu Apr 20 18:01:12 CST 2023, time=2023-04-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1209798, encodeId=8c821209e98fa, content=independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=86c21871987, createdName=ms3720148795955021, createdTime=Sat Apr 09 13:19:04 CST 2022, time=2022-04-09, status=1, ipAttribution=)]
    2022-04-09 ms3720148795955021

    independent review 快2个月了,给送审的编辑发邮件询问,也没有回应,也不知道什么情况,焦急的上蹿下跳的

    5

    展开5条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分